Header Logo

Connection

MOREY HAYMOND to Growth Hormone

Back to Details
This is a "connection" page, showing publications MOREY HAYMOND has written about Growth Hormone.
MOREY HAYMOND
Connection Strength
1.143
Growth Hormone
  1. Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res. 2005 Feb; 15(1):19-27.
    View in: PubMed
    Score: 0.233
  2. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone. Pediatr Nephrol. 1996 Jun; 10(3):318-23.
    View in: PubMed
    Score: 0.128
  3. Effect of human growth hormone and insulin-like growth factor I on whole-body leucine and estimates of protein metabolism. Horm Res. 1993; 40(1-3):92-4.
    View in: PubMed
    Score: 0.101
  4. Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol (Oxf). 1992 Feb; 36(2):161-4.
    View in: PubMed
    Score: 0.095
  5. The effects of human growth hormone and prednisone on whole body estimates of protein metabolism. Horm Res. 1992; 38 Suppl 2:44-6.
    View in: PubMed
    Score: 0.094
  6. Human growth hormone but not insulin-like growth factor I positively affects whole-body estimates of protein metabolism. Horm Res. 1992; 38 Suppl 1:73-5.
    View in: PubMed
    Score: 0.094
  7. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes. 1991 Jan; 40(1):141-9.
    View in: PubMed
    Score: 0.088
  8. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest. 1990 Jul; 86(1):265-72.
    View in: PubMed
    Score: 0.085
  9. The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab. 1976 May; 42(5):846-56.
    View in: PubMed
    Score: 0.032
  10. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res. 1996; 45(1-2):74-80.
    View in: PubMed
    Score: 0.031
  11. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes. 1993 Jul; 42(7):1082-5.
    View in: PubMed
    Score: 0.026
  12. Isolated hypoisoleucinemia impairs whole body but not hepatic protein synthesis in humans. Am J Physiol. 1991 Nov; 261(5 Pt 1):E578-86.
    View in: PubMed
    Score: 0.023
  13. Contribution of insulin resistance to catabolic effect of prednisone on leucine metabolism in humans. Diabetes. 1989 Oct; 38(10):1238-44.
    View in: PubMed
    Score: 0.020
  14. Effects of leucine, isoleucine, or threonine infusion on leucine metabolism in humans. Am J Physiol. 1987 Oct; 253(4 Pt 1):E428-34.
    View in: PubMed
    Score: 0.017
  15. Differences in circulating gluconeogenic substrates during short-term fasting in men, women, and children. Metabolism. 1982 Jan; 31(1):33-42.
    View in: PubMed
    Score: 0.012
  16. Metabolic response to hypertonic glucose administration in Reye syndrome. Ann Neurol. 1978 Mar; 3(3):207-15.
    View in: PubMed
    Score: 0.009
  17. Evaluation of growth hormone release in children using arginine and L-dopa in combination. J Pediatr. 1975 Oct; 87(4):540-4.
    View in: PubMed
    Score: 0.008
  18. Increased gluconeogenic substrates in the small-for-gestational-age infant. N Engl J Med. 1974 Aug 15; 291(7):322-8.
    View in: PubMed
    Score: 0.007
  19. Ketotic hypoglycemia: an amino acid substrate limited disorder. J Clin Endocrinol Metab. 1974 Apr; 38(4):521-30.
    View in: PubMed
    Score: 0.007
  20. Effects of exercise and weight loss on leucine turnover in different types of obesity. Am J Physiol. 1993 May; 264(5 Pt 1):E687-92.
    View in: PubMed
    Score: 0.006
  21. The use of L-DOPA in the diagnosis of hyposomatotropism in children. J Clin Endocrinol Metab. 1973 Jan; 36(1):42-6.
    View in: PubMed
    Score: 0.006
  22. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol. 1986 Mar; 250(3 Pt 1):E269-73.
    View in: PubMed
    Score: 0.004
  23. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med. 1984 Nov 08; 311(19):1214-9.
    View in: PubMed
    Score: 0.004
  24. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med. 1984 Jun 28; 310(26):1706-11.
    View in: PubMed
    Score: 0.003
  25. Effects of acute insulin deficiency on glucose and ketone body turnover in man: evidence for the primacy of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis. Diabetes. 1980 Nov; 29(11):926-30.
    View in: PubMed
    Score: 0.003
  26. Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes. 1980 Jan; 29(1):78-80.
    View in: PubMed
    Score: 0.003
  27. Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade. Am J Physiol. 1979 Feb; 236(2):E147-52.
    View in: PubMed
    Score: 0.002
  28. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976 Sep 09; 295(11):573-7.
    View in: PubMed
    Score: 0.002
  29. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest. 1976 Jul; 58(1):7-15.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.